Genentech's Receives US FDA Approval For Tarceva Tablets, EGFR Mutation Test - RTT News

MedscapeGenentech's Receives US FDA Approval For Tarceva Tablets, EGFR Mutation TestRTT NewsGenentech, a member of the Roche Group (RHHBY, ROG) Tuesday said it has received approval from the U.S. Food and Drug Administration, or FDA, for Tarceva tablets used in initial treatment of people with metastatic non-small cell lung cancer.FDA Approves Companion Genetic Diagnostic Test for Tarceva in NSCLCMedscapeFDA approves genetic test for lung cancer drug - USA TodayUSA TODAYFDA Approves Mutation Test for Lung Cancer - MedPage TodayMedPage TodayFDA.gov -Wall Street Journal -Bloombergall 12 news articles »